Charleston, SC -- (SBWIRE) -- 09/27/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Orexigen Therapeutics, Inc. (NASDAQ:OREX), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), L&L Energy, Inc. (NASDAQ:LLEN).
Orexigen Therapeutics, Inc. (NASDAQ:OREX) was among the big bulls of the prior session, as it boosted +3.50% and finished the day at the closing price of $6.51. The day range of the stock was $6.28 - $6.54 and its 52 week range remained $3.91 - $7.84. The risk relation factor, Beta of the stock remained 2.04. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Can Investors Bet on OREX after this News update? Find out in this Research Report
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) started its trading session with the price of $7.04, and closed at $7.24 by scoring +3.43%. The 52 week range of the stock was $1.08 -$7.41. BCRX traded with total volume of 1,410,000 shares, while the average trading volume remained 1.55 million shares. The beta of the stock stands at 2.98. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases.
Is BCRX a Solid Investment at These Levels? Read This Report For Details
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) traded during its last trading session with the total volume of 1,539,000 shares, as compared to its average volume of 196,369 shares. In most recent session, the stock advanced +3.26% and closed the trading activity at $4.75. Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers.
How Should Investors Trade SNSS Now? Don’t Miss out a Special Trend Analysis
L&L Energy, Inc. (NASDAQ:LLEN)’s number of shares traded in the last trading day were 3,423,300, on the other hand, its average trading volume was 2.37 million shares. In prior session, the stock advanced +3.13% and closed the trading activity at $1.32. Watching the stock’s previous 5 day trend, the stock showed a bullish move of +3.94%.L&L Energy, Inc., through its subsidiaries, engages in production, processing, and sale of coal in the People?s Republic of China.
What LLEN’s Charts Are Signaling for Traders? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)